|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6883 | (2018.01) |
| C12Q 1/6883 | (2013.01) | ||
| C12Q2600/156 | (2013.01) |
| (11) | Patento numeris | 3969620 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20730885.9 |
| Europos patento paraiškos padavimo data | 2020-05-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-03-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-06-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2020/033315 |
| Data | 2020-05-16 |
| (87) | Numeris | WO 2020/236670 |
| Data | 2020-11-26 |
| (30) | Numeris | Data | Šalis |
| 201962849670 P | 2019-05-17 | US | |
| 201962933181 P | 2019-11-08 | US |
| (72) |
DAMASK, Amy , US
PAULDING, Charles , US
BARAS, Aris , US
ABECASIS, Goncalo , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (54) | GENOME-BASED METHODS FOR REDUCING CARDIOVASCULAR RISK |
| GENOME-BASED METHODS FOR REDUCING CARDIOVASCULAR RISK |